Organogenesis Inc.

Organogenesis Inc. designs, develops and manufactures medical therapeutics containing living cells and/or natural connective tissue components. The Company's lead product, Apligraf living human skin equivalent, is currently under review at the US Food & Drug Administration for marketing approval.

Activity:

Product / Technology type(s) covered:

Therapeutic targets:

Markets Covered

a. HeadQuarter:

b. Continent(s) active:

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: